LONDON, April 10, 2014 /PRNewswire/ --
On Wednesday, April 09, 2014, the US markets saw a positive sentiment, as the NASDAQ Composite closed at 4,183.90, up 1.72%, the Dow Jones Industrial Average ended the session at 16,437.18, up 1.11%, and the S&P 500 edged 1.09% higher to finish the trading session at 1,872.18. The session saw a positive impact from Information Technology, Health Care and Materials sectors along with a drag from Utilities and Telecommunication Services sectors. A number of stocks saw large movements, including Athlon Energy Inc. (NYSE: ATHL), Venaxis Inc. (NASDAQ: APPY), Desarrolladora Homex S.A.B. de C.V. (NYSE: HXM) and ImmunoGen Inc. (NASDAQ: IMGN). Free technical research on ATHL, APPY, HXM and IMGN can be downloaded upon signing up at:
http://www.investor-edge.com/1018-register
Shares in Athlon Energy Inc. finished Wednesday's session at $37.94, up 13.12%, recording a new 52-week high of $38.94. A total of 2.22 million shares traded which is above its three months average volume of 0.67 million shares. The stock vacillated between $34.16 and $38.94 during the session. The stock advanced 3.15% in the last one month, 35.94% in the previous three months, and 25.42% on YTD basis. The S&P 500 Energy Sector Index mapped a gain of 0.48% during the trading session and charted up 2.95% in the last one month. Additionally, the stock has a Relative Strength Index (RSI) of 39.14 and is trading above its 50-day moving average of $34.54. On April 08, the company announced that it has entered into multiple definitive agreements with five unrelated third-party sellers to acquire certain producing properties and undeveloped acreage for an aggregate purchase price of $873 million in cash. Sign up today to read free research on ATHL at:
http://www.investor-edge.com/1018-ATHL-10Apr2014.pdf
On Wednesday, Venaxis Inc.'s stock ended the day at $2.24, which is 10.34% higher than the previous day's closing price of $2.03. A total of 1.58 million shares were traded as compared to its three months average volume of 0.76 million shares. During the session, the stock oscillated between $2.07 and $2.32. Shares of Venaxis Inc. have gained 3.23% in the previous three trading sessions and 4.67% on YTD basis, while the same has lost 14.99% in the last one month. The S&P 500 Health Care Sector Index mapped a gain of 2.11% during the trading session, while the same has declined 2.01% in the last one month. Further, the stock has an RSI of 31.61 and is trading above its 200-day moving average of $1.97. Sign up today to read free research on APPY at:
http://www.investor-edge.com/1018-APPY-10Apr2014.pdf
Shares in Desarrolladora Homex S.A.B. de C.V. edged 10.71% higher, finishing Wednesday's session at $1.55. A total of 0.80 million shares were traded as compared with its three months average volume of 0.71 million shares. The stock fluctuated between $1.42 and $1.63 during the trading session. Shares in Desarrolladora Homex S.A.B. de C.V. have rallied 13.97% in the last one month, 40.91% in the previous three months, and 32.48% on YTD basis. The S&P 500 Consumer Discretionary Sector Index mapped a gain of 1.08% during the trading session, while the same has declined 3.84% in the last one month. Furthermore, the stock has an RSI of 47.03 and is trading below its 50-day and 200-day moving averages of $1.62 and $1.82, respectively. Sign up today to read free research on HXM at:
http://www.investor-edge.com/1018-HXM-10Apr2014.pdf
ImmunoGen Inc.'s shares closed Wednesday's session at $14.74, up 6.50% with a trading volume of 1.11 million shares as compared with its three months average volume of 0.83 million shares. The stock traded between $13.87 and $14.84 during the session and has gone up 0.48% on YTD basis. Shares in ImmunoGen Inc. have surged 10.91% in the previous three trading sessions, while the same has fallen by 7.64% in the last one month. The S&P 500 Health Care Sector Index mapped a gain of 2.11% during the trading session and 2.86% in the previous three months. Moreover, the stock has an RSI of 37.46 and is trading below its 50-day and 200-day moving averages of $15.65 and $16.18, respectively. Sign up today to read free research on IMGN at:
http://www.investor-edge.com/1018-IMGN-10Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
